熱門資訊> 正文
TransCode Therapeutics重新与纳斯达克合规
2024-06-10 19:12
- TransCode Therapeutics (NASDAQ:RNAZ) said it has received notice from Nasdaq, stating that the company has regained compliance with all applicable Nasdaq listing standards.
- As a result, the company’s stock will remain listed and traded on Nasdaq.
More on TransCode Therapeutics
- Seeking Alpha’s Quant Rating on TransCode Therapeutics
- Historical earnings data for TransCode Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
